Zobrazeno 1 - 10
of 1 889
pro vyhledávání: '"S.J. Enna"'
Autor:
S.J. Enna
Publikováno v:
Biochemical pharmacology. 206
Autor:
S.J. Enna
Publikováno v:
Biochemical Pharmacology. 212:115499
Autor:
S.J. Enna
Publikováno v:
Biochemical Pharmacology. 203:115189
Autor:
John F. Cryan, David H. Farb, Norman G. Bowery, Wolfgang Foestl, Klemens Kaupmann, S.J. Enna, Bernhard Bettler, Jean-Philippe Pin
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2021
Functional GABAB receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on GABAB receptors [11, 71]) are formed from the heterodimerization of two similar 7TM subunits termed GABAB1 and GABAB2 [11, 70, 28, 71, 87]. GABAB receptors are widesp
Autor:
Klemens Kaupmann, Bernhard Bettler, Norman G. Bowery, David H. Farb, S.J. Enna, Jean-Philippe Pin, Wolfgang Foestl, John F. Cryan
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2019
Functional GABAB receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on GABAB receptors [11, 72]) are formed from the heterodimerization of two similar 7TM subunits termed GABAB1 and GABAB2 [11, 71, 28, 72, 85]. GABAB receptors are widesp
Autor:
Kiyofumi Yamada, Filippo Drago, Michael Spedding, Carmine M. Pariante, Wim van den Brink, Joseph Zohar, Gil Zalsman, S.J. Enna, Siegfried Kasper, Filippo Caraci, George F. Koob, Pier Vincenzo Piazza, Giorgio Racagni
Publikováno v:
British Journal of Clinical Pharmacology. 83:1614-1616
The Neuroscience-based Nomenclature (NbN) for psychotropic drugs was developed as an alternative to the current Anatomical Therapeutic Chemical (ATC) indication-based classification in order to provide more precise designations for this drug class. T
Autor:
S.J. Enna, Jacques Piette
Publikováno v:
Biochemical pharmacology. 153
Autor:
Michael F. Jarvis, S.J. Enna
Publikováno v:
Biochemical pharmacology. 151
Autor:
David B. Bylund, S.J. Enna
Although Solomon Snyder authored hundreds of research reports and several books covering a broad range of topics in the neurosciences, he is best known by many as the person who developed neurotransmitter receptor radioligand binding assays. By demon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b6885f7566a7c3ac3000eb65d7018f8
https://doi.org/10.1016/bs.apha.2017.08.007
https://doi.org/10.1016/bs.apha.2017.08.007
Publikováno v:
Biochemical Pharmacology. 97:225-235
Recent reports have highlighted studies in biomedical research that cannot be reproduced, tending to undermine the credibility, relevance and sustainability of the research process. To address this issue, a number of factors can be monitored to impro